Cargando…

Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study

BACKGROUND: Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the synthesis of γ-aminobutyric acid (GABA). Anti-GAD antibodies (GADA) are associated with the progression of stiff person syndrome and other neurological diseases, as well as the immune-mediated (type 1) diabetes. GABA is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Masahito, Ishigaki, Yasushi, Uno, Kenji, Sawada, Shojiro, Imai, Junta, Kaneko, Keizo, Hasegawa, Yutaka, Yamada, Tetsuya, Tokita, Ai, Iseki, Kazumi, Kanno, Shigenori, Nishio, Yoshiyuki, Katagiri, Hideki, Mori, Etsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711917/ https://www.ncbi.nlm.nih.gov/pubmed/23835051 http://dx.doi.org/10.1186/1471-2377-13-76

Ejemplares similares

Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report
por: Takagi, Masahito, et al.
Publicado: (2011)

Simultaneous Copy Number Losses within Multiple Subtelomeric Regions in Early-Onset Type2 Diabetes Mellitus
por: Kodama, Shinjiro, et al.
Publicado: (2014)

A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals
por: Uno, Kenji, et al.
Publicado: (2015)

Impacts of the Great East Japan Earthquake on diabetic patients
por: Tanaka, Mamiko, et al.
Publicado: (2015)

Interleukin-6 Enhances Glucose-Stimulated Insulin Secretion From Pancreatic β-Cells: Potential Involvement of the PLC-IP(3)–Dependent Pathway
por: Suzuki, Toshinobu, et al.
Publicado: (2011)

Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report
por: Kaneko, Keizo, et al.
Publicado: (2019)

Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation
por: Izumi, Tomohito, et al.
Publicado: (2018)

Extraordinarily long-inactive solitary fibrous tumor transformed to produce big insulin-like growth factor-2, leading to hypoglycemia and rapid liposarcoma growth: a case report
por: Kaneko, Keizo, et al.
Publicado: (2020)

Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism
por: Yamamoto, Junpei, et al.
Publicado: (2017)

MicroRNAs 106b and 222 Improve Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes via Pancreatic β-Cell Proliferation
por: Tsukita, Sohei, et al.
Publicado: (2016)

Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study
por: Kubo, Haremaru, et al.
Publicado: (2022)

A change in brain white matter after shunt surgery in idiopathic normal pressure hydrocephalus: a tract-based spatial statistics study
por: Kanno, Shigenori, et al.
Publicado: (2017)

Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
por: Sato, Toshihiro, et al.
Publicado: (2022)

Olfactory receptors are expressed in pancreatic β-cells and promote glucose-stimulated insulin secretion
por: Munakata, Yuichiro, et al.
Publicado: (2018)

Cognitive Profile of Idiopathic Normal Pressure Hydrocephalus
por: Saito, Makoto, et al.
Publicado: (2011)

Native Valve Endocarditis due to Staphylococcus warneri Developing in a Patient with Type 1 Diabetes
por: Yamamoto, Junpei, et al.
Publicado: (2020)

Inhibition of Plasminogen Activator Inhibitor-1 Activation Suppresses High Fat Diet-Induced Weight Gain via Alleviation of Hypothalamic Leptin Resistance
por: Hosaka, Shinichiro, et al.
Publicado: (2020)

Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice
por: Chiba, Yumiko, et al.
Publicado: (2016)

Liver Transplantation for Homozygous Familial Hypercholesterolemia
por: Ishigaki, Yasushi, et al.
Publicado: (2019)

Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
por: Honma, Midori, et al.
Publicado: (2018)

Three Distinct Glutamate Decarboxylase Genes in Vertebrates
por: Grone, Brian P., et al.
Publicado: (2016)

Molecular Analysis of Glutamate Decarboxylases in Enterococcus avium
por: Gu, Xinyi, et al.
Publicado: (2021)

A highly sensitive strategy for monitoring real-time proliferation of targeted cell types in vivo
por: Sugawara, Hiroto, et al.
Publicado: (2023)

Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies
por: Herard, Kimberly, et al.
Publicado: (2019)

Parallel Strategy Increases the Thermostability and Activity of Glutamate Decarboxylase
por: Zhang, Qing-Fei, et al.
Publicado: (2020)

A case of fulminant type 1 diabetes and protein C deficiency complicated by deep vein thrombosis
por: Kohata, Masato, et al.
Publicado: (2023)

Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodies
por: Aoyama, Tomohisa, et al.
Publicado: (2012)

Neural substrates underlying progressive micrographia in Parkinson's disease
por: Kanno, Shigenori, et al.
Publicado: (2020)

Impaired perception of illusory contours and cortical hypometabolism in patients with Parkinson’s disease
por: Ishioka, Toshiyuki, et al.
Publicado: (2021)

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995)

Calmodulin-dependent and calmodulin-independent glutamate decarboxylases in apple fruit
por: Trobacher, Christopher P, et al.
Publicado: (2013)

Anti-glutamic acid decarboxylase antibody positive neurological syndromes
por: Tohid, Hassaan
Publicado: (2016)

Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023)

Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment
por: Hatayama, Satoko, et al.
Publicado: (2022)

Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti‐glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme‐linked immunosorbent assay
por: Takagi, Satoshi, et al.
Publicado: (2019)

Mirror writing and cortical hypometabolism in Parkinson’s disease
por: Shinohara, Mayumi, et al.
Publicado: (2022)

Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase
por: Jaeckel, Elmar, et al.
Publicado: (2003)

Limbic encephalitis with antibodies to glutamic acid decarboxylase presenting with brainstem symptoms
por: Incecik, Faruk, et al.
Publicado: (2015)

Identification and molecular cloning of glutamate decarboxylase gene from Lactobacillus casei
por: Tavakoli, Yasaman, et al.
Publicado: (2015)

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression
por: Wu, Xueyan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6oatoes7364jedg96qu2ukj8eb